OpenEvidence

Miami, FL · Founded 2017 · Privately Held (backing)

Developer of an AI-powered information platform designed to organize medical knowledge and make it useful, accessible, and understandable. OpenEvidence is based in Miami, FL and was founded in 2017. It was valued at $15 billion at its Series E in Sep 2026, the last priced event on record. It has raised $795 million across 11 recorded rounds; the latest was a $250 million Series E in Sep 2026.

PMV mark · valuation
$15.0B
Oct 2026
Priced at
its Series E
Sep 2026
Total raised
$795.4M
Last round
Series E
Sep 2026
Prints on record
6
Price range
▮
Latest print
May 2026
First print
Mar 2026
Pro
The prices on OpenEvidence
  • ·Every dated print: 6 trades with prices and structures
  • ·Price per share on 6 rounds
  • ·1 investment vehicle formed around OpenEvidence: sponsors, sizes, dates
  • ·Direct lines for 6 people on the team
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

OpenEvidence market activity

prints per month, every source

6 trades between Mar 2026 and May 2026. Exact dates, prices and structures are available to Pro members.

Mar 2026peak 3 prints / monthMay 2026
Individual prints are Pro.Unlock 6 trade prints

Membership and data by Private Market View

Where OpenEvidence prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of OpenEvidence stock.